Preoperative chemoradiation

RADIATION2 trials

Sponsors

Oslo University Hospital, Essentia Health

Conditions

Adenocarcinoma of AmpullaDuctal Adenocarcinoma of PancreasRectal Cancer

Phase 2

Oxaliplatin and 5-FU Based Preoperative Chemoradiation

CompletedNCT00278694

Oslo University HospitalRectal Cancer

Start: 2005-09-30End: 2016-02-29Updated: 2016-09-29

Phase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or Ampulla

TerminatedNCT02626520

Essentia HealthAdenocarcinoma of Ampulla, Ductal Adenocarcinoma of Pancreas

Start: 2016-05-11End: 2017-09-14Updated: 2018-11-13

Related Papers

Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer.

2019-05-2741 citations

High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer

BMC Cancer2019-05-2313 citations

Circulating vitamin D during neoadjuvant therapy in high-risk rectal cancer.

Journal of Clinical Oncology2018-05-20

Abstract 1782: Reactive oxygen species (ROS) and mitochondrial DNA (mtDNA) damage in tumor hypoxia, poor radiotherapy response, and metastatic progression of rectal cancer

Cancer Research2017-07-013 citations

Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening.

2016-07-264 citations

Abstract 4006: Oxaliplatin-induced immune factors and long-term disease control in rectal cancer - a reflection of immunogenic tumor cell death

Cancer Research2016-07-151 citations

Abstract C101: Circulating tumor necrosis factor receptor (TNFR) proteins in systemic disease outcome to combined-modality radiotherapy in rectal cancer

Molecular Cancer Therapeutics2015-12-01

Abstract 571: Circulating proteins in response to combined-modality therapy in locally advanced rectal cancer identified by antibody array screening

Cancer Research2015-08-01

Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer.

2015-07-2414 citations

Abstract B29: High tumor PI3K signaling in resistance to chemoradiotherapy and metastatic dissemination of locally advanced rectal cancer

Molecular Cancer Therapeutics2015-07-01

Tumor phosphatidylinositol 3-kinase signaling in therapy resistance and metastatic dissemination of rectal cancer: opportunities for signaling-adapted therapies.

2015-01-1215 citations